PMC3402017_01
PMC3402017_02
Comparison of self-reported PTSD Symptom Scale clusters for hydrocortisone and placebo treated PE participants.
EJPT-1-5643-g001.jpg
PMC3402017_02_EJPT-1-5643-g001.jpg
F0001
A showed a 54 point reduction in CAPS and a 20 point reduction on PSS-SR, reflecting a substantial decrease in PTSD symptom severity. As illustrated in Fig. 1 (panels A, B, and C), the patient experienced some reduction in all symptoms clusters, but his reduction in avoidance symptoms was greater (58.8% reduction as assessed by PSS-SR) than the reduction he experienced in either re-experiencing or hyperarousal symptoms. His post-treatment CAPS score was 42 points lower than at pre-treatment and his PSS-SR showed a 7 point reduction which, as shown in Fig. 1 (panels A, B, and C), reflected a small decrease within each symptom cluster.